Korean Drug Balance Sheet Health
Financial Health criteria checks 6/6
Korean Drug has a total shareholder equity of ₩77.1B and total debt of ₩0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ₩89.7B and ₩12.6B respectively. Korean Drug's EBIT is ₩6.7B making its interest coverage ratio -5.6. It has cash and short-term investments of ₩16.8B.
Key information
0%
Debt to equity ratio
₩0
Debt
| Interest coverage ratio | -5.6x |
| Cash | ₩16.76b |
| Equity | ₩77.09b |
| Total liabilities | ₩12.62b |
| Total assets | ₩89.71b |
Recent financial health updates
No updates
Recent updates
Should You Be Adding Korean Drug (KOSDAQ:014570) To Your Watchlist Today?
Mar 11
Korean Drug (KOSDAQ:014570) Is Growing Earnings But Are They A Good Guide?
Feb 19
Korean Drug Co., Ltd.'s (KOSDAQ:014570) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Feb 01Is Korean Drug Co., Ltd. (KOSDAQ:014570) Popular Amongst Insiders?
Jan 11Can You Imagine How Jubilant Korean Drug's (KOSDAQ:014570) Shareholders Feel About Its 111% Share Price Gain?
Dec 24Here's Why I Think Korean Drug (KOSDAQ:014570) Might Deserve Your Attention Today
Dec 06Are Korean Drug's (KOSDAQ:014570) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Nov 18Financial Position Analysis
Short Term Liabilities: A014570's short term assets (₩63.4B) exceed its short term liabilities (₩9.9B).
Long Term Liabilities: A014570's short term assets (₩63.4B) exceed its long term liabilities (₩2.7B).
Debt to Equity History and Analysis
Debt Level: A014570 is debt free.
Reducing Debt: A014570 had no debt 5 years ago.
Debt Coverage: A014570 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: A014570 has no debt, therefore coverage of interest payments is not a concern.